Complications Requiring Hospital Admission and Causes of In-Hospital Death over Time in Alcoholic and Nonalcoholic Cirrhosis Patients
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Data on the epidemiology of alcoholic cirrhosis, especially in Asian countries, are limited. We compared the temporal evolution of patterns of alcoholic and nonalcoholic cirrhosis over the last decade. Methods: We retrospectively examined the inpatient datasets of five referral centers during 2002 and 2011. The study included patients who were admitted due to specific complications of liver cirrhosis. We compared the causes of hospital admissions and in-hospital deaths between patients with alcoholic and nonalcoholic cirrhosis. Results: Among the included 2,799 hospitalizations (2,165 patients), 1,496 (1,143 patients) were from 2002, and 1,303 (1,022 patients) were from 2011. Over time, there was a reduction in the rate of hepatic encephalopathy (HE) as a cause of hospitalization and an increase in the rate of hepatocellular carcinoma. Deaths that were attributable to HE or spontaneous bacterial peritonitis (SBP) significantly decreased, whereas those due to hepatorenal syndrome (HRS) significantly increased over time in patients with alcoholic cirrhosis. However, in patients with nonalcoholic cirrhosis, hepatic failure and HRS remained the principal causes of in-hospital death during both time periods. Conclusions: The major causes of in-hospital deaths have evolved from acute cirrhotic complications, including HE or SBP to HRS in alcoholic cirrhosis, whereas those have remained unchanged in nonalcoholic cirrhosis during the last decade.
Abstract
Background/Aims: Data on the epidemiology of alcoholic cirrhosis, especially in Asian countries, are limited. We compared the temporal evolution of patterns of alcoholic and nonalcoholic cirrhosis over the last decade. Methods: We retrospectively examined the inpatient datasets of five referral centers during 2002 and 2011. The study included patients who were admitted due to specific complications of liver cirrhosis. We compared the causes of hospital admissions and in-hospital deaths between patients with alcoholic and nonalcoholic cirrhosis. Results: Among the included 2,799 hospitalizations (2,165 patients), 1,496 (1,143 patients) were from 2002, and 1,303 (1,022 patients) were from 2011. Over time, there was a reduction in the rate of hepatic encephalopathy (HE) as a cause of hospitalization and an increase in the rate of hepatocellular carcinoma. Deaths that were attributable to HE or spontaneous bacterial peritonitis (SBP) significantly decreased, whereas those due to hepatorenal syndrome (HRS) significantly increased over time in patients with alcoholic cirrhosis. However, in patients with nonalcoholic cirrhosis, hepatic failure and HRS remained the principal causes of in-hospital death during both time periods. Conclusions: The major causes of in-hospital deaths have evolved from acute cirrhotic complications, including HE or SBP to HRS in alcoholic cirrhosis, whereas those have remained unchanged in nonalcoholic cirrhosis during the last decade.
참고문헌 (21)
- Heron M, "Deaths: leading causes for 2008", Natl Vital Stat Rep, 60, pp.1~94 (2008)
- Annual report on the cause of death statistics 2011, "Statistics Korea", Statistics Korea, ~ (2012)
- Chatterjee R, "An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer", Int Immunopharmacol, 24, pp.335~345 (2015)
- Mitra A, "IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice", Hepatology, 60, pp.2027~2039 (2014)
- Schuppan D, "Liver cirrhosis", Lancet, 371, pp.838~851 (2008)
- YoungSunKim, "The Prognosis of Liver Cirrhosis in Recent Years in Korea", Journal of Korean Medical Science, 18(6), pp.833~841 (2003), 대한의학회
- Han YS, "The change of the etiology, complications and cause of death of the liver cirrhosis in 1990s", Korean J Hepatol, 6, pp.328~339 (2000)
- Kim CY, "Natural history and survival rate of chronic liver diseases in Korea: 20 years prospective analysis", Korean J Med, 46, pp.168~180 (1994)
- Seo KS, "The cause and complication of liver cirrhosis during the reccent 5 years", Korean J Hepatol, 3, pp.202~209 (1997)
- Ahn BM, "An analysis of the causes of liver cirrhosis and complications of portal hypertension in recent years", Korean J Hepatol, 9(4), pp.S29~S36 (2003)
- Han EK, "Liver cirrhosis: etiological diagnosis and morphological characteristics of 369 biopsy-proven cases", Korean J Pathol, 24, pp.412~422 (1990)
- Liver cirrhosis mortality in the United States, 1970-2003, "Yoon YH", National Institute on Alcohol Abuse and Alcoholism, ~, pp.Surveillance Report No. 75 (2006)
- 정우진, "음주의 사회경제적 비용 추계", 예방의학회지, 39(1), pp.21~29 (2006), 대한예방의학회
- Kim KA, "Current status of liver diseases in Korea: toxic and alcoholic liver diseases", Korean J Hepatol, 15(6), pp.S29~S33 (2009)
- Amano K, "Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis B virus infection: a field survey between 2000 and 2012", Mol Clin Oncol, 2, pp.927~934 (2014)
- Singal AG, "Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis", PLoS Med, 11, pp.e1001624~ (2014)
- Kanwal F, "Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection", Gastroenterology, 140(e1), pp.1182~1188 (2011)
- Bass NM, "Rifaximin treatment in hepatic encephalopathy", N Engl J Med, 362, pp.1071~1081 (2010)
- Rimola A, "Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis", Diagn Microbiol Infect Dis, 22, pp.141~145 (1995)
- Sort P, "Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis", N Engl J Med, 341, pp.403~409 (1999)
- Sagi SV, "Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials", J Gastroenterol Hepatol, 25, pp.880~885 (2010)